Borowicz, D. et al. 2022. Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? CyberKnife, IMRT and VMAT in low risk prostate cancer. Radiology and Oncology. 56, 2 (Jul. 2022), 259–266.